Filing Details

Accession Number:
0001610717-25-000129
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-05-23 16:46:16
Reporting Period:
2025-05-21
Filing Date:
2025-05-23
Accepted Time:
2025-05-23 16:46:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1837607 Aeon Biopharma Inc. AEON () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1366841 Jost Fischer 5 Park Plaza, Suite 1750
Irvine CA 92614
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2025-05-21 60,000 $0.49 266,785 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This transaction was executed in multiple trades in prices ranging from $0.4659 to $0.4999, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.